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Remembering The History            
        
MMWintrobe the pioneer       
          
In 2014 we are celebrating the 80th anniversary of  Maxwell Myer 
Wintrobe´s pioneer publications, one of  the most important 
contributions in Clinical and Laboratory Medicine. Red cell in-
dices, widely known as Wintrobe´s indices, continue to provide 
an essential support to the diagnosis and classification of  anemia. 
From the measurements of  the average volume and Hemoglobin 
(Hb) concentration of  erythrocytes, the underlying etiology of  
anemia was brilliantly unveiled [1-4].
Anemia is a disease itself, but it is often symptomatic of  other 
illness; every clinician deals with anemia in daily practice, taking 
into account that concomitant anemia makes the prognosis of  the 
underlying disease worse for those patients.
His textbook Clinical Hematology, first published in 1942 and now 
in its 13th edition [5], remains a prototype of  excellence and for 
many years stood alone as the premier text in the field. He had 
written and edited the first six editions by himself, though always 
depending on the critical peer review of  his talented colleagues at 
Utah University, with his wife Becky, as he said his severest and 
most helpful critic [6].
Hematology, the Blossoming of  a Science: A Story of  Inspiration and Effort 
was published on 1985, shortly before his demise [7].  Writing this 
book partially as his memoirs, partially as history, Wintrobe real-
ized that he could never cover the lives of  all who had contributed 
to what he called "the Golden Age of  Hematology”.
Wintrobe’s methods were based on manual measurements of  
hemoglobin, hematocrit and erythrocyte count. Reading his arti-
cles published the 30’s [1-4], his concern with the accuracy of  the 
methods and the reliability of  the measurements become evident. 
First, he proposed a classification of  anemia, based on the new 
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indices. Then he brilliantly postulated the link with red cell mor-
phology to deduce the real etiology of  each type of  anemia. 
The erythrocyte indices mean corpuscular volume (MCV), mean 
corpuscular hemoglobin concentration (MCHC) and mean cor-
puscular hemoglobin (MCH) were derived from precisely meas-
ured values of  Hb, hematocrit and red cell count are called the 
Wintrobe indices, in honor of  Wintrobe’s invention [8].
The complete blood count (CBC; also called full blood count or 
hemogram, depending on geographical region) is one of  the most 
frequently requested tests by clinicians and the indices are still 
applied for classifying anemia. The analysis nowadays is totally 
automated and correct interpretation of  the results requires reu-
niting knowledge about the characteristics of  the measurement 
equipment and the clinical meaning of  the results [9].
The birth of  automation      
                
The first attempt in automation of  blood cell counts was the in-
troduction of  the Coulter Principle. While under contract to the 
United States Navy, Wallace H. Coulter developed a technology 
for counting and sizing particles using impedance measurements 
in the late 1940s, though a patent was not awarded until October 
20, 1953. The technology was principally developed for counting 
blood cells quickly by measuring the changes in electrical con-
ductance when cells suspended in a conductive fluid pass through 
a small orifice. Presently, the automated cell counters incorporate 
this technology, which is referred to as the Coulter Principle.
Using electronic count and pulse height analyzer circuits, the 
number of  particles and volume of  each particle passing through 
the aperture can be measured. When the volume of  liquid passing 
through the aperture can be precisely controlled and measured, 
the cell concentration in the blood sample can also be determined 
A typical measurement using Coulter type instruments takes less 
than a minute, as counting and sizing rates of  up to 10,000 parti-
cles per second are well possible. The precision of  the size meas-
urements is generally better than 1% [10].
Hematology automation has progressed steadily since Wallace 
Coulter first impedance his technology to blood. By the 1980s, 
most hematology laboratories were reporting out a 7-parameter 
CBC and three-part white blood cell (WBC) differential, all ob-
tained from a single aspiration of  a small volume of  blood in a 
stand-alone, bench-top instrument. Eventually, this process was 
upgraded even further when it became possible to obtain these 
results without uncapping the sample.
An often overlooked fact is that individual red cell volume de-
termination is dependent on the technology used by a specific 
hematology analyzers and that hematocrit value is calculated 
from the measured MCV. The only red cell index that is consist-
ent throughout all hematology analyzers is MCH, which is derived 
from precisely measured values of  Hb and red cell count [8].
In the 90’s the analyzers became capable of  quantifying the heter-
ogeneity in red cell volume, which resulted in the red cell distribu-
tion width (RDW), which is adding remarkably useful information 
to MCV. MCV is the mean of  the volumes of  all erythrocytes, 
whereas RDW refers to the dispersion of  cells with different 
volumes present in the whole population, so the contribution of  
marginally sized subsets to the calculated mean value can be as-
sessed [11].
Although RDW is generally expressed as a coefficient of  varia-
tion of  the distributions of  erythrocyte volume, some hematol-
ogy analyzers calculate RDW from the direct measurement of  the 
width of  the distribution [12].
Technological Progress
Erythrocytes
Optical technology combined with flow cytometry for measuring 
physical and chemical characteristics of  cells constituted another 
breakthrough in automated hematology analyzers. 
The basic purpose of  the optics bench in a flow cytometer is to 
detect light scattered by cells as they pass through a flow cell il-
luminated by a light beam, most often a laser beam. The scattered 
light harbors information on the cell size, its surface and internal 
structures. When scattered light is measured under different an-
gles, these data can be combined in multiple dimensions, allowing 
discrimination of  different cell types [13].
Optical flow cytometric technology for RBC measurement was 
first made available by the then Technicon Company in their H* 
series of  instruments, later followed by the Advia® hematology 
analyzers (Bayer Diagnostics, presently Siemens Healthcare Di-
agnostics, Deerfield, IL, USA). This optical technology enables 
measuring, simultaneous and independently, the cellular Hb 
concentration of  individual erythrocytes as well as their volume, 
derived from light scatter by isovolumetrically sphered RBC ac-
cording to the Mie theory [14,15]. Mie theory describes the math-
ematics of  light diffraction by spherical objects, in this case the 
red cells, which are transformed into isovolumetric spheres. When 
using monochromatic laser light, diffraction is only a function of  
the size and the refractive index of  the object, which in erythro-
cytes is directly related to the cell’s Hb concentration. 
In the red cell/platelet channel, red cells are converted to spheres. 
Using Mie theory, low-angle (2°-3°) and high-angle (5°-15°) light 
scatter is measured and mathematical models in the software use 
these scatter signals for calculating the size and cellular hemo-
globin concentration (CHC) of  individual red cells.
Both measurements can be provided as a 2-dimensional scatter-
gram. In this graph, the volume of  individual red cells is plotted 
on the y-axis, and their intracellular hemoglobin concentration on 
the x-axis. In addition to a graphical representation, also quantita-
tive data can be derived from these measurements: hypochromic 
RBC with CHC < 280 g/L,  hyperchromic RBC with CHC > 410 
g/L, microcytic with volume < 60 fL and macrocytic with volume 
> 120 fL
Technicon Instruments was the first manufacturer to offer a com-
plete set of  extended RBC parameters in their H*3 hematology 
analyzer [16] and this explains why the majority of  literature on 
these parameters was produced using this analyzer and its succes-
sors of  the Advia series (Siemens Healthcare Diagnostics, Deer-
field, IL, USA).
More recently, Abbott (Abbott Diagnostics, Santa ClaraCA, USA) 
introduced extended RBC parameters on the CELL-DYN Sap-
phire analyzer. These are calculated from three-dimensional laser 
light scatter, applying the principles of  the Mie theory, which is 
basically the same as in the Advia analyzers [17,18].
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Over the past years, other manufacturers have started offering 
extended RBC parameters, although differences in the technology 
used make it impossible to directly compare the numerical values 
of  RBC parameters derived from different instruments. 
Sysmex analyzers XE-5000 and XN-series (Sysmex Corporation, 
Kobe, Japan) report some RBC extended parameters, the percent-
ages of  erythrocyte subsets. In the reticulocyte channel hypochro-
mic and hyperchromic erythrocytes are quantified, but it is impor-
tant to highlight that is Hb content, not cellular Hb concentration, 
what is reported. Hypochromic red cells by Sysmex are those with 
an Hb content less than 17 pg, while hyperchromic are those with 
Hbover  49pg [19].
Because of  the relatively long life span of  mature erythrocytes, 
the classical Wintrobe indices reflect the overall erythrocyte pro-
duction and iron incorporation into Hb over the last 2-3 months. 
As previously mentioned in the 80s the analyzers were capable 
to quantify the heterogeneity in distribution of  both mean cell 
volume (RDW) adding a remarkable useful information to MVC. 
This is not the case for MHC. Calculated from red blood cell 
count and Hb, MCH represents the average.
But different set of  numbers can render nearly the same mean. 
In order to describe mathematically a set two types of  measures 
are necessary centralization measures (more abundant individu-
als) and of  dispersion, giving insight on the heterogeneity of  the 
population. 
The percentage of  subsets can give complementary information 
of  the contribution of  cell with extreme values (hypochromic and 
hyperchromic cells) to the mean values, MCH. The percentages 
reflects howHb is distributed in the individual cells, in a uniform 
way or not; if  polychromasia is present, the fluctuations of  iron 
availability to the erythron in the previous weeks can be high-
lighted [11,20].
Similar application of  those technologies is being introduced by 
other companies (Mindray Biomedical Electronics, Nanchang, 
Shenzhen, China) on their analyzers [21].
Reticulocytes          
                                  
Reticulocytes are immature red blood cells with a life span of  only 
1 to 2 days. The reticulocyte count represents an important test 
in the study of  marrow erythropoietic activity. In clinical practice 
it can be used for diagnosis (distinguishing hemolytic or post-
hemorrhagic anemias from hypoplasticanemias), in monitoring 
therapy (megaloblastic anemia, iron deficiency), or as a way of  
checking early regeneration after marrow or stem cell transplant. 
The presence of  cytoplasmatic RNA is the basic difference with 
mature red cells which is employed for detecting this minor frac-
tion from the RBC whole population.
The reticulocytes are classically  identified by optical microscopy, 
using supravital stain (brillantcresyl blue, new methylene blue) 
that binds to ribosomal RNA. The manual/visual method of  
counting reticulocytes evaluates the number of  reticulocytes in a 
total of  1000 RBCs [22]. 
The additional technological progress in the last 10–15 years has 
resulted in automated measurements of  the number of  reticu-
locytes and cellular reticulocyte parameters. Starting in the mid-
1990s [23], different stains binding RNA are used to distinguish 
reticulocytes, some fluorescence (cyanine dye, Abbott; Thiazole 
orange, Horiba; polymethine, Sysmex) or by absorbance (Oxa-
zine, Siemens; new mehtylene blue, Beckman-Coulter) [8].
During the last years, flow cytometry has become the reference 
technique for measuring absolute reticulocyte counts and param-
eters of  reticulocyte maturation [24,25].
Automated techniques for reticulocyte enabled the integration of  
reticulocyte analysis with the complete blood count in automated 
hematology analyzers. The advantages derived from automation 
are high throughput, improve precision and reliability of  reticulo-
cyte counts compared to microscope  review (essentially owing to 
the high number of  cells counted) [23],[26-28].
In summary, technological advances being incorporated into he-
matology analyzers since Wintrobe´s days are now allowing the 
access to more cellular information than was ever available before 
through a “simple routine CBC “ [29,30].
The added information contained in the “new extended hemo-
gram“ has proven its usefulness in certain clinical conditions: ane-
mia of  chronic disease, functional iron deficiency and monitor-
ing the availability of  iron during treatment with erythropoietin 
[11,17],[31-40] thalassemia trait screening [41-43] spherocytosis 
[44,45] iron deficiency and latent iron deficiency [46-58]. 
In all these clinical conditions, common in our daily practice, the 
added information in the contemporary hemogram aids the clini-
cians to make a rapid and reliable diagnosis, without additional 
costs. Enabling the clinician to get a prompt accurate diagnosis 
reduces unnecessary testing and avoids inappropriate treatment, 
which results in an efficient use of  the resources of  the Health 
Systems.
The Promising XXITH Century
Current research is beginning to demonstrate that this informa-
tion also has great potential to identify cellular changes that typi-
cally occur in several important medical conditions—bringing us 
all one step closer to using hematology analyzers as more than 
simple cell counters, but instead as powerful tools for the man-
agement of  any medical condition that impacts the biology of  
blood cells.
In physiological conditions, bone marrow produces 200*109 red 
blood cells per day; the body normally loses the same number 
through senescence, maintaining an overall steady state but little 
is known about the life cycle of  120 days of  RBC.
Novel and promising research [59] has shed new light on the re-
lationship between Hb content, Hb concentration and red cell 
volume. Using a systems- biology approach the dynamics of  cir-
culating red cells can be analyzed, linking the changes of  volume 
and Hb concentration to red cell lifespan and removal.
The mechanisms that regulate the number, size, and hemoglobin 
concentration of  normal red cells in circulation are not well un-
derstood. It has been established, however, that after their release 
from the bone marrow red cells undergo a reduction in volume 
and total hemoglobin content. Higgins and Mahadevan [59] used 
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theory from statistical physics together with standard red cell in-
dexes derived from electronic cell counters and the information 
generated by flow cytometry, to develop a master equation for the 
maturation and clearance of  red cells. Their mathematical model 
implies that the total number of  red cells added to the circulation 
equals the number removed and suggests that there is a threshold 
value for the MCHC below which red cells are cleared from the 
circulation [60]. The model distinguishes the dynamics of  red cell 
population in healthy subjects from those of  patients suffering 
from iron deficiency, thalassemia or anemia of  chronic disease 
[59].
As has been exposed, manufacturers have developed fine hema-
tology analyzers that achieve high levels of  precision and accuracy 
in cell counting through the examination and identification of  
many thousands, not hundreds, of  cells in each sample analyzed. 
In this way there are increasing amounts of  data provided, which 
require specialist knowledge to interpret as well as to understand 
the limitations in the measurement of  the parameter. Both labo-
ratory scientists and clinicians need to keep up to date with new 
parameters and methods in hematology, implying a stronger col-
laboration between them. Good laboratory practice ensures that 
reliable results of  laboratory tests are reported to the clinician 
[61].
The modern clinical hematology laboratory is subject to strong 
pressure to provide clinically relevant information that can help 
clinicians to make a diagnosis in a fast, cheap and useful manner, 
but we must not forget the words by Max Wintrobe: 
“And yet, we must not stop exploring and measuring, for there is always 
more to learn”
Happy anniversary!
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